OMass Therapeutics Takes on ‘Undruggable’ Proteins with €90M Series B
The UK firm OMass Therapeutics has unveiled a €90M (£75.5M) Series B financing to bankroll…
The UK firm OMass Therapeutics has unveiled a €90M (£75.5M) Series B financing to bankroll…
In a show of strength after an income squeeze during the Covid-19 pandemic, the charity…
The startup Forcefield Therapeutics has been unveiled in the UK with €6M (£5.5M) backing from…
After gathering huge investment funds in 2021, European biotech investors took a breather in the…
A Covid-19 vaccine developed by the French company Valneva has received the green light from…
As wars and inflation buffet European markets, private biotech companies raised fewer investments in March…
The UK-US venture capitalist Epidarex Capital has led an €11M (£9M) funding round raised by…
The EU has followed the FDA in granting market approval to Kimmtrak, the first-ever bispecific…
The World Health Organization has released a 10-year plan to monitor the genetic make-up of…
In the last two years, Russian Covid-19 vaccine makers had a tough time penetrating the…
Low-cost genetic sequencing is becoming increasingly accessible and profitable for companies, but data protection and…
BIO-Europe Spring is one of Europe's biggest biotech partnering events with discussion topics ranging from…